1. Chemoradiation and granulocyte-colony or granulocyte macrophage-colony stimulating factors (G-CSF or GM-CSF): time to think out of the box?
    Marouan Benna et al, 2020, The British Journal of Radiology CrossRef
  2. Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target
    Zhengxiao Ouyang et al, 2019, Cell Communication and Signaling CrossRef
  3. Genetic and Modifiable Risk Factors Contributing to Cisplatin-induced Toxicities
    Matthew R. Trendowski et al, 2019, Clinical Cancer Research CrossRef
  4. Risk Factors for Febrile Neutropenia in Children With Solid Tumors Treated With Cisplatin-based Chemotherapy
    Osvaldo D. Castelán-Martínez et al, 2016, Journal of Pediatric Hematology/Oncology CrossRef
  5. Elevated Risk of Fluoropyrimidine-Associated Toxicity in European Patients with DPYD Genetic Polymorphism: A Systematic Review and Meta-Analysis
    Woorim Kim et al, 2022, Journal of Personalized Medicine CrossRef
  6. Trilobolide-6-O-isobutyrate from Sphagneticola trilobata acts by inducing oxidative stress, metabolic changes and apoptosis-like processes by caspase 3/7 activation of human lung cancer cell lines
    Virginia Marcia Concato-Lopes et al, 2024, Phytomedicine CrossRef
  7. Toxic effects of cancer therapies
    Shweta Ingole et al, 2024, Public Health and Toxicology Issues Drug Research, Volume 2 CrossRef
  8. Research Progress on Colony-Stimulating Factor Combined with Radiotherapy to Fight Tumor Immunomodulation
    峻 张, 2024, Advances in Clinical Medicine CrossRef
  9. Bufalin Inhibits Proliferation and Induces Apoptosis in Osteosarcoma Cells by Downregulating MicroRNA-221
    Jianjun Zhang et al, 2016, Evidence-Based Complementary and Alternative Medicine CrossRef
  10. Anemia and Bone Marrow Suppression After Intra-Arterial Chemotherapy in Children With Retinoblastoma: A Retrospective Analysis
    Changjuan Zeng et al, 2022, Frontiers in Oncology CrossRef
  11. Malnutrition as Risk Factor for Febrile Neutropenia in Children with Acute Lymphoblastic Leukemia
    Hanzelina Hanzelina et al, 2022, Open Access Macedonian Journal of Medical Sciences CrossRef
  12. Prospective Observational Study on the Risk Factors of Chemotherapy-Induced Myelosuppression and Its Management in a Tertiary Care Hospital
    D. Keziah et al, 2023, Indian Journal of Medical and Paediatric Oncology CrossRef
  13. Association between malnutrition and leucopenia in patients with osteosarcoma
    Haixiao Wu et al, 2022, Frontiers in Nutrition CrossRef
  14. Temozolomide associated to gold nanoparticles promoted a synergic effect and apoptosis when exposed to melanoma cells
    Giulia dos Santos Pedroso-Fidelis et al, 2022, Journal of Nanoparticle Research CrossRef
  15. Incidence and determinants of hematotoxicity in acute lymphoblastic leukemia children who received 6-mercaptopurine based maintenance therapy in Addis Ababa, Ethiopia
    Awol Mekonnen Ali et al, 2023, PLOS ONE CrossRef
  16. Overexpression of GSDMC is a prognostic factor for predicting a poor outcome in lung adenocarcinoma
    Jie Wei et al, 2019, Molecular Medicine Reports CrossRef
  17. Infectious Morbidity in Pediatric Patients Receiving Neoadjuvant Chemotherapy for Sarcoma
    Denise Willmer et al, 2021, Cancers CrossRef
  18. Intermittent fasting and its impact on toxicities, symptoms and quality of life in patients on active cancer treatment
    Robert Li Sucholeiki et al, 2024, Cancer Treatment Reviews CrossRef